Stanford University Medical Center

CO-1686, a Third Generation Drug for EGFR Positive Lung Cancer Patients

Article

Dr. Heather Wakelee of Stanford University Medical Center talks about a drug still in development for EGFR lung cancer patients, CO-1686. February 2014.

[powerpress]

Read more about CO-1686, a Third Generation Drug for EGFR Positive Lung Cancer Patients

What's the Status and Potential Utility of Cabozantinib in Lung Cancer?

Article

Dr. Heather Wakelee of Stanford University Medical Center discusses whether or not cabozantinib - a drug already approved for thyroid cancer - can help patients with lung cancer. February 2014.

[powerpress]

Read more about What's the Status and Potential Utility of Cabozantinib in Lung Cancer?

Subscribe to Stanford University Medical Center